Cross-talk among MEN1, p53 and Notch regulates the proliferation of pancreatic neuroendocrine tumor cells by modulating INSM1 expression and subcellular localization-Reference-Cited by-同舟云学术

Cross-talk among MEN1, p53 and Notch regulates the proliferation of pancreatic neuroendocrine tumor cells by modulating INSM1 expression and subcellular localization

Published:2021-09 Issue:9 Volume:23 Page:979-992
ISSN:1476-5586
Container-title:Neoplasia
language:en
Short-container-title:Neoplasia

Author:

Capodanno Ylenia,Chen Yu,Schrader Joerg,Tomosugi Mitsuhiro,Sumi Shoiciro,Yokoyama Akihiko,Hiraoka Nobuyoshi,Ohki Rieko

Publisher

Elsevier BV

Subject

Cancer Research

Reference50 articles.

1. Current understanding of the molecular biology of pancreatic neuroendocrine tumors;Zhang;J Natl Cancer Inst,2013

2. Differences and similarities in the clinicopathological features of pancreatic neuroendocrine tumors in China and the United States: A multicenter study;Zhu;Medicine (Baltimore),2016

3. Pancreatic endocrine neoplasms: Epidemiology and prognosis of pancreatic endocrine tumors;Halfdanarson;Endocr Relat Cancer,2008

4. Prognostic factors of non-functioning pancreatic neuroendocrine tumor revisited: The value of WHO 2010 classification;Bu;Ann Hepato-Biliary-Pancreatic Surg,2018

5. Whole-genome landscape of pancreatic neuroendocrine tumours;Scarpa;Nature,2017

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Endoscopic ultrasonography-based intratumoral and peritumoral machine learning radiomics analyses for distinguishing insulinomas from non-functional pancreatic neuroendocrine tumors;Frontiers in Endocrinology;2024-06-17

2. Metabolic intervention by low carbohydrate diet suppresses the onset and progression of neuroendocrine tumors;Cell Death & Disease;2023-09-07

3. UBE1C is upregulated and promotes neddylation of p53 in lung cancer;The FASEB Journal;2023-09-05

4. Medical Needs and Therapeutic Options for Melanoma Patients Resistant to Anti-PD-1-Directed Immune Checkpoint Inhibition;Cancers;2023-06-30

5. p53-Dependent Cytoprotective Mechanisms behind Resistance to Chemo-Radiotherapeutic Agents Used in Cancer Treatment;Cancers;2023-06-28